Bracco and Arrayus Partner to Boost Pancreatic Cancer Drug Delivery Using Focused Ultrasound and Microbubbles
Deal Overview Bracco Imaging S.A., a global leader in diagnostic imaging, has agreed with Arrayus...
Read MoreMonth: September 2024
FDA Action Update: Designations (19th September 2024)
Glycomine received FTD for GLM101 Glycomine, Inc. has received FDA Fast Track Designation for GLM101, a mannose-1-phosphate replacement therapy aimed at treating phosphomannomutase 2-congenital disorder of glycosylation...
Read MoreRegulatory Tracker FDA: 19th September 2024
BriaCell Unveils FDA-Approved EAP for Metastatic Breast Cancer Treatment BriaCell Therapeutics has received U.S. FDA authorization for its Expanded Access Policy (EAP) to offer Bria-IMT™, an innovative immunotherapy, to...
Read More
Nexxt Spine Introduces Struxxure Modular Cervical System for Personalized Surgical Solutions
Nexxt Spine has announced the launch of the Struxxure® Modular Cervical System (MCS), a new...
Read MoreMannKind Receives PMDA Clearance for Phase 3 Trial of Clofazimine Inhalation Suspension for NTM Lung Disease
MannKind Corporation has announced clearance from Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) to begin the Phase 3 clinical trial (ICoN-1) of its Clofazimine Inhalation Suspension for treating nontuberculous...
Read More